antaitavir hasophate (HEC74647PA)
/ HEC Pharm
- LARVOL DELTA
Home
Next
Prev
1 to 15
Of
15
Go to page
1
April 12, 2023
Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis C
(clinicaltrials.gov)
- P2/3 | N=520 | Recruiting | Sponsor: Sunshine Lake Pharma Co., Ltd. | Trial completion date: Dec 2022 ➔ Apr 2023 | Trial primary completion date: Dec 2022 ➔ Apr 2023
Combination therapy • Trial completion date • Trial primary completion date • Hepatitis C • Hepatology • Infectious Disease • Inflammation
January 05, 2023
ADME Study of [14C] Antaitavir Hasophate in Healthy Male Subjects
(clinicaltrials.gov)
- P1 | N=6 | Completed | Sponsor: Sunshine Lake Pharma Co., Ltd. | Recruiting ➔ Completed
Trial completion
December 21, 2022
Pharmacokinetics of Midazolam When Co-administered With HEC74647 and HEC110114
(clinicaltrials.gov)
- P1 | N=14 | Completed | Sponsor: Sunshine Lake Pharma Co., Ltd. | Recruiting ➔ Completed
Trial completion
October 31, 2022
ADME Study of [14C] Antaitavir Hasophate in Healthy Male Subjects
(clinicaltrials.gov)
- P1 | N=8 | Recruiting | Sponsor: Sunshine Lake Pharma Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open
October 26, 2022
Pharmacokinetics of Midazolam When Co-administered With HEC74647 and HEC110114
(clinicaltrials.gov)
- P1 | N=14 | Recruiting | Sponsor: Sunshine Lake Pharma Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open
August 17, 2022
Pharmacokinetics of Midazolam When Co-administered With HEC74647 and HEC110114
(clinicaltrials.gov)
- P1 | N=14 | Not yet recruiting | Sponsor: Sunshine Lake Pharma Co., Ltd.
New P1 trial
July 06, 2022
ADME Study of [14C] Antaitavir Hasophate in Healthy Male Subjects
(clinicaltrials.gov)
- P1 | N=8 | Not yet recruiting | Sponsor: Sunshine Lake Pharma Co., Ltd.
New P1 trial
May 27, 2022
Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis C
(clinicaltrials.gov)
- P2/3 | N=520 | Recruiting | Sponsor: Sunshine Lake Pharma Co., Ltd.
Combination therapy • New P2/3 trial • Hepatitis C • Hepatology • Infectious Disease • Inflammation
November 05, 2020
Drug-drug Interaction Study Between HEC74647PA Capsule and HEC110114 Tablets in Healthy Subjects
(clinicaltrials.gov)
- P1; N=28; Completed; Sponsor: Sunshine Lake Pharma Co., Ltd.; Recruiting ➔ Completed
Clinical • Trial completion • Hepatitis C Virus • Hepatology • Infectious Disease
August 07, 2020
Drug-drug Interaction Study Between HEC74647PA Capsule and HEC110114 Tablets in Healthy Subjects
(clinicaltrials.gov)
- P1; N=28; Recruiting; Sponsor: Sunshine Lake Pharma Co., Ltd.; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open • Hepatitis C Virus • Infectious Disease
May 28, 2020
Drug-drug Interaction Study Between HEC74647PA Capsule and HEC110114 Tablets in Healthy Subjects
(clinicaltrials.gov)
- P1; N=28; Not yet recruiting; Sponsor: Sunshine Lake Pharma Co., Ltd.; Initiation date: Apr 2020 ➔ Jul 2020
Clinical • Trial initiation date • Hepatitis C Virus • Infectious Disease
March 19, 2020
The Tolerability and Pharmacokinetics Study of HEC74647PA Capsule in Healthy Adult Subjects
(clinicaltrials.gov)
- P1; N=105; Completed; Sponsor: Sunshine Lake Pharma Co., Ltd.; Trial completion date: Nov 2019 ➔ Jul 2019
Clinical • Trial completion date
March 19, 2020
The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC74647 in HCV-infected Subjects
(clinicaltrials.gov)
- P1; N=28; Completed; Sponsor: Sunshine Lake Pharma Co., Ltd.; Not yet recruiting ➔ Completed; Trial completion date: Sep 2020 ➔ Jan 2020; Trial primary completion date: Jun 2020 ➔ Jan 2020
Clinical • Trial completion • Trial completion date • Trial primary completion date
March 19, 2020
Drug-drug Interaction Study Between HEC74647PA Capsule and HEC110114 Tablets in Healthy Subjects
(clinicaltrials.gov)
- P1; N=28; Not yet recruiting; Sponsor: Sunshine Lake Pharma Co., Ltd.; Trial completion date: Jul 2020 ➔ Oct 2020; Trial primary completion date: Apr 2020 ➔ Jul 2020
Clinical • Trial completion date • Trial primary completion date
January 18, 2020
Drug-drug Interaction Study Between HEC74647PA Capsule and HEC110114 Tablets in Healthy Subjects
(clinicaltrials.gov)
- P1; N=28; Not yet recruiting; Sponsor: Sunshine Lake Pharma Co., Ltd.
Clinical • New P1 trial
1 to 15
Of
15
Go to page
1